摘要
A number of researches concerning pharmacology of traditional medicine and active natural products over the past 12 months have outlined the importance of reviewing the progress.This annual integrative pharmacology review evaluates researches published during 2018 in different diseases including cardiovascular and cerebrovascular diseases,cancers,diabetes and metabolic diseases,and so on.The emphasis is on bioactive compounds and extracts from traditional herbs,as well as the novel molecular targets and mechanisms.Moreover,some traditional prescriptions in China and other geographical locations have also been included.
基金
the National Natural Science Foundation of China (Nos.81773932,30873072 and 81530097) and the National Key Technology R&D Program "New Drug Innovation" of China (No.2018ZX09711001-008-003).
